Research & Development



  童百泉家,黎斯是最後一個來到這里的人,一進門黎斯就看到了一張張臉,牛嫂、邢郎中、福小生、童百泉、童杰,吳聞走過來問︰“大人,發生了什麼事,半夜里把這麼多人叫來?”   在大明南直隸甦州府太倉州唯亭鎮街上一家豆腐坊的樓上,張泰正仔細地往一張黃裱紙上刷著漿糊,準備補一下被昨天的暴雨打破了的窗紙,突然說著。伊人久久大香蕉网在线   說來也怪,劉戰斗一見這三樣東西,面色頓時大變。他對電話里敷衍了幾句,趕緊掛斷,看我的時候,兩眼幾乎要冒出火來。伊人久久大香蕉网   馬伯庸   “你的話太多了。不管如何,他從隱示局里逃了出來,也就完成了教主對于他的第一個考驗,之後的事就非你我可以插手的了。”女子聲若清蓮,“我勸你不要多事,以免引火自焚。”青青视频网   我不是打給鄭教授或劉一鳴,而是打給圖書館。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo